chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Body temperature increased, Cellulitis, Chest pain
Clinical narrative: nasopharyngeal congestion; ear popping; feverish feeling; night sweats; sob sensation; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; temperature instability 97-100F; joint pain; achy spine; heel cellulitis; paresthesias; This is a spontaneous report received from contactable physician ((patient) reported for herself). A 47-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: Ek9231, expiry date not reported), intramuscular, administered in left arm on 29Dec2020 12:00 (age at vaccination as 47 years old) as first dose, single for COVID-19 immunization. The patient had no medical history and no known allergies. The patient was not pregnant at the time of vaccination and of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN BAMBINI), zinc chloride, vitamin c (ascorbic acid), vitamin D, and zinc; all taken for an unspecified indication, start and stop date were not reported. Facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Dec2020 08:00 AM, day 1, heel cellulitis and paresthesias started. On day 4, 02Jan2021, nasopharyngeal congestion, ear popping, feverish feeling, night sweats, sob sensation, "throbbing in face, nose, throat, chest, and head", temperature instability 97-100F. On an unknown date in 2021, patient had joint pain, headaches, achy spine for 4 months. Currently, patient was on treatment for heel cellulitis, and have been out of work since vaccine.  Patient's symptoms have waxed and waned and still present. The reported events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events reported, which included antibiotics for several times.  The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, has the patient been tested for COVID-19 which included PCR (nasal swab) on 12Jan2021 which was negative. The outcome of the events was not recovered.; Sender's Comments: The event cellulitis is likely intercurrent and is unrelated to suspect product BNT162B2.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Ear discomfort, Facial pain, Headache, Night sweats
Clinical narrative: nasopharyngeal congestion; ear popping; feverish feeling; night sweats; sob sensation; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; temperature instability 97-100F; joint pain; achy spine; heel cellulitis; paresthesias; This is a spontaneous report received from contactable physician ((patient) reported for herself). A 47-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: Ek9231, expiry date not reported), intramuscular, administered in left arm on 29Dec2020 12:00 (age at vaccination as 47 years old) as first dose, single for COVID-19 immunization. The patient had no medical history and no known allergies. The patient was not pregnant at the time of vaccination and of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN BAMBINI), zinc chloride, vitamin c (ascorbic acid), vitamin D, and zinc; all taken for an unspecified indication, start and stop date were not reported. Facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Dec2020 08:00 AM, day 1, heel cellulitis and paresthesias started. On day 4, 02Jan2021, nasopharyngeal congestion, ear popping, feverish feeling, night sweats, sob sensation, "throbbing in face, nose, throat, chest, and head", temperature instability 97-100F. On an unknown date in 2021, patient had joint pain, headaches, achy spine for 4 months. Currently, patient was on treatment for heel cellulitis, and have been out of work since vaccine.  Patient's symptoms have waxed and waned and still present. The reported events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events reported, which included antibiotics for several times.  The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, has the patient been tested for COVID-19 which included PCR (nasal swab) on 12Jan2021 which was negative. The outcome of the events was not recovered.; Sender's Comments: The event cellulitis is likely intercurrent and is unrelated to suspect product BNT162B2.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Paraesthesia, Polymerase chain reaction, Pyrexia, Rhinalgia
Clinical narrative: nasopharyngeal congestion; ear popping; feverish feeling; night sweats; sob sensation; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; temperature instability 97-100F; joint pain; achy spine; heel cellulitis; paresthesias; This is a spontaneous report received from contactable physician ((patient) reported for herself). A 47-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: Ek9231, expiry date not reported), intramuscular, administered in left arm on 29Dec2020 12:00 (age at vaccination as 47 years old) as first dose, single for COVID-19 immunization. The patient had no medical history and no known allergies. The patient was not pregnant at the time of vaccination and of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN BAMBINI), zinc chloride, vitamin c (ascorbic acid), vitamin D, and zinc; all taken for an unspecified indication, start and stop date were not reported. Facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Dec2020 08:00 AM, day 1, heel cellulitis and paresthesias started. On day 4, 02Jan2021, nasopharyngeal congestion, ear popping, feverish feeling, night sweats, sob sensation, "throbbing in face, nose, throat, chest, and head", temperature instability 97-100F. On an unknown date in 2021, patient had joint pain, headaches, achy spine for 4 months. Currently, patient was on treatment for heel cellulitis, and have been out of work since vaccine.  Patient's symptoms have waxed and waned and still present. The reported events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events reported, which included antibiotics for several times.  The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, has the patient been tested for COVID-19 which included PCR (nasal swab) on 12Jan2021 which was negative. The outcome of the events was not recovered.; Sender's Comments: The event cellulitis is likely intercurrent and is unrelated to suspect product BNT162B2.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Spinal pain, Upper respiratory tract congestion
Clinical narrative: nasopharyngeal congestion; ear popping; feverish feeling; night sweats; sob sensation; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; throbbing in face, nose, throat, chest, and head; temperature instability 97-100F; joint pain; achy spine; heel cellulitis; paresthesias; This is a spontaneous report received from contactable physician ((patient) reported for herself). A 47-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: Ek9231, expiry date not reported), intramuscular, administered in left arm on 29Dec2020 12:00 (age at vaccination as 47 years old) as first dose, single for COVID-19 immunization. The patient had no medical history and no known allergies. The patient was not pregnant at the time of vaccination and of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN BAMBINI), zinc chloride, vitamin c (ascorbic acid), vitamin D, and zinc; all taken for an unspecified indication, start and stop date were not reported. Facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Dec2020 08:00 AM, day 1, heel cellulitis and paresthesias started. On day 4, 02Jan2021, nasopharyngeal congestion, ear popping, feverish feeling, night sweats, sob sensation, "throbbing in face, nose, throat, chest, and head", temperature instability 97-100F. On an unknown date in 2021, patient had joint pain, headaches, achy spine for 4 months. Currently, patient was on treatment for heel cellulitis, and have been out of work since vaccine.  Patient's symptoms have waxed and waned and still present. The reported events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events reported, which included antibiotics for several times.  The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, has the patient been tested for COVID-19 which included PCR (nasal swab) on 12Jan2021 which was negative. The outcome of the events was not recovered.; Sender's Comments: The event cellulitis is likely intercurrent and is unrelated to suspect product BNT162B2.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Chest pain, Fatigue, Feeling cold, Headache
Clinical narrative: Pain on injection site; Body aches; Chills; Headache; Back pain on left lung base; Fever (102.3) it is gone now; Tiredness; Mild chest pain on left side; Tingling on feet/Tingling on left hand; This is a spontaneous report from a contactable Other-HCP (patient).   A 34-years-old no pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in Arm Left on 12Feb2021 (Batch/Lot Number: EN6201) as 2ND  SINGLE DOSE for covid-19 immunisation. Age at vaccination 34 years. Facility type vaccine: Hospital. Medical history included migraine, penicillin allergy. No other vaccine in four weeks. Concomitant medication(s) included cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported and Theravir (Vit C, D, Zinc, Cooper, Quercetin, Melatonin).  The patient previously took lactose and experienced drug hypersensitivity, iodine and experienced drug hypersensitivity, aspirin [acetylsalicylic acid] and experienced drug hypersensitivity.The patient received the first dose brand=Pfizer Biotech COVID 19 Vaccine, lot number=EI3248, on 22Jan2021 at 10:45 AM via Intramuscular in Left arm.The patient experienced pain on injection site on 12Feb2021 21:30 with outcome of recovering , body aches on 12Feb2021 21:30 with outcome of recovering , chills (chills) (non-serious) on 12Feb2021 21:30 with outcome of recovering , headache on 12Feb2021 21:30 with outcome of recovering , back pain on left lung base on 12Feb2021 21:30 with outcome of recovering , fever (102.3) it is gone now on 12Feb2021 21:30 with outcome of recovered , tiredness on 12Feb2021 21:30 with outcome of recovering , mild chest pain on left side on 12Feb2021 21:30 with outcome of recovering , tingling on feet/tingling on left hand on 12Feb2021 21:30 with outcome of recovering.  The patient underwent lab tests and procedures which included body temperature: 102.3   on 12Feb2021  .  No treatment received for the events. No covid prior vaccination: No.No covid tested post vaccination  Follow-up attempts completed. No further information expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site pain, Pain, Paraesthesia, Pyrexia
Clinical narrative: Pain on injection site; Body aches; Chills; Headache; Back pain on left lung base; Fever (102.3) it is gone now; Tiredness; Mild chest pain on left side; Tingling on feet/Tingling on left hand; This is a spontaneous report from a contactable Other-HCP (patient).   A 34-years-old no pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in Arm Left on 12Feb2021 (Batch/Lot Number: EN6201) as 2ND  SINGLE DOSE for covid-19 immunisation. Age at vaccination 34 years. Facility type vaccine: Hospital. Medical history included migraine, penicillin allergy. No other vaccine in four weeks. Concomitant medication(s) included cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported and Theravir (Vit C, D, Zinc, Cooper, Quercetin, Melatonin).  The patient previously took lactose and experienced drug hypersensitivity, iodine and experienced drug hypersensitivity, aspirin [acetylsalicylic acid] and experienced drug hypersensitivity.The patient received the first dose brand=Pfizer Biotech COVID 19 Vaccine, lot number=EI3248, on 22Jan2021 at 10:45 AM via Intramuscular in Left arm.The patient experienced pain on injection site on 12Feb2021 21:30 with outcome of recovering , body aches on 12Feb2021 21:30 with outcome of recovering , chills (chills) (non-serious) on 12Feb2021 21:30 with outcome of recovering , headache on 12Feb2021 21:30 with outcome of recovering , back pain on left lung base on 12Feb2021 21:30 with outcome of recovering , fever (102.3) it is gone now on 12Feb2021 21:30 with outcome of recovered , tiredness on 12Feb2021 21:30 with outcome of recovering , mild chest pain on left side on 12Feb2021 21:30 with outcome of recovering , tingling on feet/tingling on left hand on 12Feb2021 21:30 with outcome of recovering.  The patient underwent lab tests and procedures which included body temperature: 102.3   on 12Feb2021  .  No treatment received for the events. No covid prior vaccination: No.No covid tested post vaccination  Follow-up attempts completed. No further information expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Body temperature, Chest pain, Chills, Fatigue
Clinical narrative: Pain on injection site; Body aches; Chills; Headache; Back pain on left lung base; Fever (102.3) it is gone now; Tiredness; Mild chest pain on left side; Tingling on feet/Tingling on left hand; This is a spontaneous report from a contactable Other-HCP (patient).   A 34-years-old no pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in Arm Left on 12Feb2021 (Batch/Lot Number: EN6201) as 2ND  SINGLE DOSE for covid-19 immunisation. Age at vaccination 34 years. Facility type vaccine: Hospital. Medical history included migraine, penicillin allergy. No other vaccine in four weeks. Concomitant medication(s) included cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported and Theravir (Vit C, D, Zinc, Cooper, Quercetin, Melatonin).  The patient previously took lactose and experienced drug hypersensitivity, iodine and experienced drug hypersensitivity, aspirin [acetylsalicylic acid] and experienced drug hypersensitivity.The patient received the first dose brand=Pfizer Biotech COVID 19 Vaccine, lot number=EI3248, on 22Jan2021 at 10:45 AM via Intramuscular in Left arm.The patient experienced pain on injection site on 12Feb2021 21:30 with outcome of recovering , body aches on 12Feb2021 21:30 with outcome of recovering , chills (chills) (non-serious) on 12Feb2021 21:30 with outcome of recovering , headache on 12Feb2021 21:30 with outcome of recovering , back pain on left lung base on 12Feb2021 21:30 with outcome of recovering , fever (102.3) it is gone now on 12Feb2021 21:30 with outcome of recovered , tiredness on 12Feb2021 21:30 with outcome of recovering , mild chest pain on left side on 12Feb2021 21:30 with outcome of recovering , tingling on feet/tingling on left hand on 12Feb2021 21:30 with outcome of recovering.  The patient underwent lab tests and procedures which included body temperature: 102.3   on 12Feb2021  .  No treatment received for the events. No covid prior vaccination: No.No covid tested post vaccination  Follow-up attempts completed. No further information expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Pain, Paraesthesia, Pyrexia, Vaccination site pain
Clinical narrative: Pain on injection site; Body aches; Chills; Headache; Back pain on left lung base; Fever (102.3) it is gone now; Tiredness; Mild chest pain on left side; Tingling on feet/Tingling on left hand; This is a spontaneous report from a contactable Other-HCP (patient).   A 34-years-old no pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in Arm Left on 12Feb2021 (Batch/Lot Number: EN6201) as 2ND  SINGLE DOSE for covid-19 immunisation. Age at vaccination 34 years. Facility type vaccine: Hospital. Medical history included migraine, penicillin allergy. No other vaccine in four weeks. Concomitant medication(s) included cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported and Theravir (Vit C, D, Zinc, Cooper, Quercetin, Melatonin).  The patient previously took lactose and experienced drug hypersensitivity, iodine and experienced drug hypersensitivity, aspirin [acetylsalicylic acid] and experienced drug hypersensitivity.The patient received the first dose brand=Pfizer Biotech COVID 19 Vaccine, lot number=EI3248, on 22Jan2021 at 10:45 AM via Intramuscular in Left arm.The patient experienced pain on injection site on 12Feb2021 21:30 with outcome of recovering , body aches on 12Feb2021 21:30 with outcome of recovering , chills (chills) (non-serious) on 12Feb2021 21:30 with outcome of recovering , headache on 12Feb2021 21:30 with outcome of recovering , back pain on left lung base on 12Feb2021 21:30 with outcome of recovering , fever (102.3) it is gone now on 12Feb2021 21:30 with outcome of recovered , tiredness on 12Feb2021 21:30 with outcome of recovering , mild chest pain on left side on 12Feb2021 21:30 with outcome of recovering , tingling on feet/tingling on left hand on 12Feb2021 21:30 with outcome of recovering.  The patient underwent lab tests and procedures which included body temperature: 102.3   on 12Feb2021  .  No treatment received for the events. No covid prior vaccination: No.No covid tested post vaccination  Follow-up attempts completed. No further information expected.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: cold urticaria/, I now develop hives and swelling when out in cold temperatures <37 degrees Fahrenheit; swelling when out in cold temperatures; This is a spontaneous report from a contactable Nurse (reporting for herself). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EL9261) intramuscularly in left arm on 05Feb2021 14:00 as 2nd single dose and had previously received (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EK4176) intramuscularly on 15Jan2021 14:00 as 1st single dose for COVID-19 immunization. The patient was 26-years-old and was not pregnant at the time of vaccination. The patient medical history included severe plaque psoriasis, celiac disease, chronic insomnia and known allergies to corn, scallops, clams, sulfa drugs, gluten, shellfish and benzoyl peroxide. The concomitant medications were zolpidem tartrate (AMBIEN), trazodone, doxycycline, birth control and ustekinumab (STELARA). The vaccination facility type was Hospital. No other vaccine was administered in last four weeks. The patient was not given any prior COVID-19 vaccination. The patient was not tested for COVID-19 post vaccination. On 06Feb2021 at 14:00, patient developed cold urticaria, and developed hives and on 06Feb2021 at 13:30 developed swelling when out in cold temperatures <37 degrees Fahrenheit or touching something cold for longer than a minute. Was seen by a doctor who diagnosed this condition, and he believes that it is directly related to the covid vaccine. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment for the event which included antihistamines. The outcome of the events was not recovered.   Follow-up (15Feb2021): This is a follow-up spontaneous report from a contactable Physician. This Physician reported for a patient which included additional allergies what the patient was suffering with, updated timing and route of administration for the first and second dose of vaccination. The treatment received status updated as Yes previously reported as No as updated in the initial narrative.   Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cold urticaria, Swelling
Clinical narrative: cold urticaria/, I now develop hives and swelling when out in cold temperatures <37 degrees Fahrenheit; swelling when out in cold temperatures; This is a spontaneous report from a contactable Nurse (reporting for herself). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EL9261) intramuscularly in left arm on 05Feb2021 14:00 as 2nd single dose and had previously received (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EK4176) intramuscularly on 15Jan2021 14:00 as 1st single dose for COVID-19 immunization. The patient was 26-years-old and was not pregnant at the time of vaccination. The patient medical history included severe plaque psoriasis, celiac disease, chronic insomnia and known allergies to corn, scallops, clams, sulfa drugs, gluten, shellfish and benzoyl peroxide. The concomitant medications were zolpidem tartrate (AMBIEN), trazodone, doxycycline, birth control and ustekinumab (STELARA). The vaccination facility type was Hospital. No other vaccine was administered in last four weeks. The patient was not given any prior COVID-19 vaccination. The patient was not tested for COVID-19 post vaccination. On 06Feb2021 at 14:00, patient developed cold urticaria, and developed hives and on 06Feb2021 at 13:30 developed swelling when out in cold temperatures <37 degrees Fahrenheit or touching something cold for longer than a minute. Was seen by a doctor who diagnosed this condition, and he believes that it is directly related to the covid vaccine. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment for the event which included antihistamines. The outcome of the events was not recovered.   Follow-up (15Feb2021): This is a follow-up spontaneous report from a contactable Physician. This Physician reported for a patient which included additional allergies what the patient was suffering with, updated timing and route of administration for the first and second dose of vaccination. The treatment received status updated as Yes previously reported as No as updated in the initial narrative.   Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bradykinesia, Fatigue, Headache, Rash
Clinical narrative: Patient woke up a multitude of small bumps all over my body. They were either skin toned or pinkish but not red; They have not gone away. They feel uncomfortable; The bumps look like goosebumps but larger and not as evenly distributed as my normal pores.; This is a spontaneous report from a contactable consumer or other non hcp. A 41-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 16Feb2021 12:30 (Batch/Lot Number: EN5318) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included asthma, some cholesterol and slightly elevated blood pressure. Not allergic to any foods or meds but allergic to cats. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication(s) included zn [zinc] (ZN [ZINC]) taken for an unspecified indication, start and stop date were not reported; ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported; elderberry [sambucus nigra] (ELDERBERRY SUPPLEMENT) taken for an unspecified indication, start and stop date were not reported and MULTIVITAMIN taken for an unspecified indication, start and stop date were not reported.The patient previously received first dose of BNT162B2 via unspecified route of administration, administered in Arm Left on 26Jan2021 02:30 PM (Batch/Lot Number: EN5318) for covid-19 immunisation. The next morning of the second vaccine on 17Feb2021 at 10:00 AM the patient woke up with a multitude of small bumps all over her body. They were either skin toned or pinkish but not red. They have not gone away. They feel uncomfortable. They were neither painful nor overly itchy. They were not on her calves or feet or hands or face but mostly cover her torso and arms and were all over her back. It was questioned that was this a Covid type rash or was this a skin allergy. The bumps look like goosebumps but larger and not as evenly distributed as her normal pores. The outcome of the events were not recovered. It was unknown whether the treatment was received for the events. The outcome of the events were not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Piloerection, Skin discolouration
Clinical narrative: Patient woke up a multitude of small bumps all over my body. They were either skin toned or pinkish but not red; They have not gone away. They feel uncomfortable; The bumps look like goosebumps but larger and not as evenly distributed as my normal pores.; This is a spontaneous report from a contactable consumer or other non hcp. A 41-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 16Feb2021 12:30 (Batch/Lot Number: EN5318) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included asthma, some cholesterol and slightly elevated blood pressure. Not allergic to any foods or meds but allergic to cats. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication(s) included zn [zinc] (ZN [ZINC]) taken for an unspecified indication, start and stop date were not reported; ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported; elderberry [sambucus nigra] (ELDERBERRY SUPPLEMENT) taken for an unspecified indication, start and stop date were not reported and MULTIVITAMIN taken for an unspecified indication, start and stop date were not reported.The patient previously received first dose of BNT162B2 via unspecified route of administration, administered in Arm Left on 26Jan2021 02:30 PM (Batch/Lot Number: EN5318) for covid-19 immunisation. The next morning of the second vaccine on 17Feb2021 at 10:00 AM the patient woke up with a multitude of small bumps all over her body. They were either skin toned or pinkish but not red. They have not gone away. They feel uncomfortable. They were neither painful nor overly itchy. They were not on her calves or feet or hands or face but mostly cover her torso and arms and were all over her back. It was questioned that was this a Covid type rash or was this a skin allergy. The bumps look like goosebumps but larger and not as evenly distributed as her normal pores. The outcome of the events were not recovered. It was unknown whether the treatment was received for the events. The outcome of the events were not recovered.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Induration, Limb discomfort, Lymphadenopathy, Pain, Swelling
Clinical narrative: Extremely swollen lymph nodes on left side of body.; Very swollen chest above left breast. Difficult to move and very painful.; Very swollen chest above left breast. Difficult to move and very painful.; This is a spontaneous report from a contactable consumer. This 35-year-old female consumer reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EN6201), via an unspecified route of administration on 18Feb2021 at 03:30 pm in left arm as single dose for covid-19 immunsation. The patient's medical history included GERD and known allergies: penicillin. Historical vaccine included bnt162b2 on 28Jan2021 (Lot number: EL9265, Administration time: 06:00 PM, Vaccine location: Left arm, Dose number: 1). Concomitant medications included esomeprazole sodium (NEXIUM), ergocalciferol (VITAMIN D), cyanocobalamin (VITAMIN B12), fish oil (OMEGA 3). Past drugs included Reglan, penicillin, Tetracyclines for allergies. On 19Feb2021, the patient experienced extremely swollen lymph nodes on left side of body, stretching from armpit area up to neck, very swollen chest above left breast and difficult to move and very painful. The patient did not take any treatment for the events. The outcome of the events was not recovered
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breast swelling, Lymphadenopathy, Pain
Clinical narrative: Extremely swollen lymph nodes on left side of body.; Very swollen chest above left breast. Difficult to move and very painful.; Very swollen chest above left breast. Difficult to move and very painful.; This is a spontaneous report from a contactable consumer. This 35-year-old female consumer reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EN6201), via an unspecified route of administration on 18Feb2021 at 03:30 pm in left arm as single dose for covid-19 immunsation. The patient's medical history included GERD and known allergies: penicillin. Historical vaccine included bnt162b2 on 28Jan2021 (Lot number: EL9265, Administration time: 06:00 PM, Vaccine location: Left arm, Dose number: 1). Concomitant medications included esomeprazole sodium (NEXIUM), ergocalciferol (VITAMIN D), cyanocobalamin (VITAMIN B12), fish oil (OMEGA 3). Past drugs included Reglan, penicillin, Tetracyclines for allergies. On 19Feb2021, the patient experienced extremely swollen lymph nodes on left side of body, stretching from armpit area up to neck, very swollen chest above left breast and difficult to move and very painful. The patient did not take any treatment for the events. The outcome of the events was not recovered
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Pruritus, Rash
Clinical narrative: Mild itching on both upper arms; Minor Diarrhea/ mild Diarrhea; Minor skin rash on left upper arms and right leg/Mild Skin rash on both upper arms; This is a spontaneous report from a contactable consumer (patient).  A 66-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 10Feb2021 09:15 (Batch/Lot Number: EL9267) at the age of 66-year-old; as single dose for covid-19 immunisation.  Medical history included hypertension from an unknown date and unknown if ongoing, drug hypersensitivity to Penicillin from an unknown date and unknown if ongoing, seasonal allergy from an unknown date and unknown if ongoing.  Concomitant medication included amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported.   The patient experienced minor skin rash on left upper arms and right leg/mild skin rash on both upper arms (rash) (non-serious) on 10Feb2021 21:15 with outcome of recovering , minor diarrhea/ mild diarrhea (diarrhoea) (non-serious) on 11Feb2021 with outcome of recovering , mild itching on both upper arms (pruritus) (non-serious) on 13Feb2021 13:00 with outcome of recovering.  The action taken in response to the event(s) for bnt162b2 was not applicable.  Therapeutic measures were taken as a result of minor skin rash on left upper arms and right leg/mild skin rash on both upper arms (rash), mild itching on both upper arms (pruritus).  Follow-up attempts completed. No further information expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Axillary mass, Headache, Magnetic resonance imaging, Myalgia
Clinical narrative: arm pit sore (day 1, 2, 3, 4)/arm extremely sore (day 2); arm pit sore; tricep/bicep muscle extremely tight/tricep/bicep still very sore and tight; Lump under arm pit; finger felt slightly numb/finger tips felt a little numb; This is a spontaneous report from a contactable other health professional (patient self- reported). A 30-year-old female patient (age at vaccination: 30 Year) received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9265 and expiry date was not provided), via an unspecified route of administration, in Arm Right, on 04Feb2021 at 10:00 AM, as a single dose for COVID-19 immunization at hospital. The patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3246 and expiry date was not provided), via an unspecified route of administration, in Arm Left, on 08Jan2021 at 02:00 PM, as a single dose for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the was not patient diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was reported that on 04Feb2021, the patient had lump under arm pit, and finger felt slightly numb/finger tips felt a little numb. On an unknown date, the patient had arm pit sore (day 1, 2, 3, 4)/arm extremely sore (day 2), and lump in arm pit (day 3), tricep/bicep muscle extremely tight (day 3, 4, 5) which hurts when she tried to extend arm to reach. currently trying to see if event will subside within a few days but may be reaching out to her doctor if stiffness in her arm did not subside. The patient did not receive any treatment for the events lump under arm pit, finger felt slightly numb/finger tips felt a little numb. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Tinnitus
Clinical narrative: arm pit sore (day 1, 2, 3, 4)/arm extremely sore (day 2); arm pit sore; tricep/bicep muscle extremely tight/tricep/bicep still very sore and tight; Lump under arm pit; finger felt slightly numb/finger tips felt a little numb; This is a spontaneous report from a contactable other health professional (patient self- reported). A 30-year-old female patient (age at vaccination: 30 Year) received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9265 and expiry date was not provided), via an unspecified route of administration, in Arm Right, on 04Feb2021 at 10:00 AM, as a single dose for COVID-19 immunization at hospital. The patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3246 and expiry date was not provided), via an unspecified route of administration, in Arm Left, on 08Jan2021 at 02:00 PM, as a single dose for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the was not patient diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was reported that on 04Feb2021, the patient had lump under arm pit, and finger felt slightly numb/finger tips felt a little numb. On an unknown date, the patient had arm pit sore (day 1, 2, 3, 4)/arm extremely sore (day 2), and lump in arm pit (day 3), tricep/bicep muscle extremely tight (day 3, 4, 5) which hurts when she tried to extend arm to reach. currently trying to see if event will subside within a few days but may be reaching out to her doctor if stiffness in her arm did not subside. The patient did not receive any treatment for the events lump under arm pit, finger felt slightly numb/finger tips felt a little numb. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Hypoaesthesia, Mass, Muscle tightness, Pain in extremity
Clinical narrative: arm pit sore (day 1, 2, 3, 4)/arm extremely sore (day 2); arm pit sore; tricep/bicep muscle extremely tight/tricep/bicep still very sore and tight; Lump under arm pit; finger felt slightly numb/finger tips felt a little numb; This is a spontaneous report from a contactable other health professional (patient self- reported). A 30-year-old female patient (age at vaccination: 30 Year) received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9265 and expiry date was not provided), via an unspecified route of administration, in Arm Right, on 04Feb2021 at 10:00 AM, as a single dose for COVID-19 immunization at hospital. The patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3246 and expiry date was not provided), via an unspecified route of administration, in Arm Left, on 08Jan2021 at 02:00 PM, as a single dose for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the was not patient diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was reported that on 04Feb2021, the patient had lump under arm pit, and finger felt slightly numb/finger tips felt a little numb. On an unknown date, the patient had arm pit sore (day 1, 2, 3, 4)/arm extremely sore (day 2), and lump in arm pit (day 3), tricep/bicep muscle extremely tight (day 3, 4, 5) which hurts when she tried to extend arm to reach. currently trying to see if event will subside within a few days but may be reaching out to her doctor if stiffness in her arm did not subside. The patient did not receive any treatment for the events lump under arm pit, finger felt slightly numb/finger tips felt a little numb. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Fatigue, Pain in extremity, Somnolence, Urticaria
Clinical narrative: she passed out; she had swelling of her lymph nodes; cold chills; cold sweats; threw up; She thought she was going to have a heart attack; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date as single dose for COVID-19 immunization. The patient had minor side effects with the first COVID vaccine.  With the second shot on unspecified date, the patient had swelling of her lymph nodes. A week later from the shot, she passed out. She has never passed out before in her life. This week two days ago, she had cold chills, cold sweats, and threw up. She was in the bathroom from both ends. She thought she was going to have a heart attack. She went to the doctor for a check-up. The patient had a CAT scan, and a heart monitor to rule out a TIA on unspecified date with unknown results. She cannot believe it because she is normally a healthy person. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anxiety, Asthenia, Cold sweat, Computerised tomogram, Diarrhoea
Clinical narrative: she passed out; she had swelling of her lymph nodes; cold chills; cold sweats; threw up; She thought she was going to have a heart attack; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date as single dose for COVID-19 immunization. The patient had minor side effects with the first COVID vaccine.  With the second shot on unspecified date, the patient had swelling of her lymph nodes. A week later from the shot, she passed out. She has never passed out before in her life. This week two days ago, she had cold chills, cold sweats, and threw up. She was in the bathroom from both ends. She thought she was going to have a heart attack. She went to the doctor for a check-up. The patient had a CAT scan, and a heart monitor to rule out a TIA on unspecified date with unknown results. She cannot believe it because she is normally a healthy person. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Feeling abnormal, Head discomfort, Head injury, Headache, Hyperventilation
Clinical narrative: she passed out; she had swelling of her lymph nodes; cold chills; cold sweats; threw up; She thought she was going to have a heart attack; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date as single dose for COVID-19 immunization. The patient had minor side effects with the first COVID vaccine.  With the second shot on unspecified date, the patient had swelling of her lymph nodes. A week later from the shot, she passed out. She has never passed out before in her life. This week two days ago, she had cold chills, cold sweats, and threw up. She was in the bathroom from both ends. She thought she was going to have a heart attack. She went to the doctor for a check-up. The patient had a CAT scan, and a heart monitor to rule out a TIA on unspecified date with unknown results. She cannot believe it because she is normally a healthy person. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Investigation, Loss of consciousness, Lymphadenopathy, Pain in extremity, Peripheral swelling
Clinical narrative: she passed out; she had swelling of her lymph nodes; cold chills; cold sweats; threw up; She thought she was going to have a heart attack; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date as single dose for COVID-19 immunization. The patient had minor side effects with the first COVID vaccine.  With the second shot on unspecified date, the patient had swelling of her lymph nodes. A week later from the shot, she passed out. She has never passed out before in her life. This week two days ago, she had cold chills, cold sweats, and threw up. She was in the bathroom from both ends. She thought she was going to have a heart attack. She went to the doctor for a check-up. The patient had a CAT scan, and a heart monitor to rule out a TIA on unspecified date with unknown results. She cannot believe it because she is normally a healthy person. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Tremor, Vertigo, Vomiting
Clinical narrative: she passed out; she had swelling of her lymph nodes; cold chills; cold sweats; threw up; She thought she was going to have a heart attack; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date as single dose for COVID-19 immunization. The patient had minor side effects with the first COVID vaccine.  With the second shot on unspecified date, the patient had swelling of her lymph nodes. A week later from the shot, she passed out. She has never passed out before in her life. This week two days ago, she had cold chills, cold sweats, and threw up. She was in the bathroom from both ends. She thought she was going to have a heart attack. She went to the doctor for a check-up. The patient had a CAT scan, and a heart monitor to rule out a TIA on unspecified date with unknown results. She cannot believe it because she is normally a healthy person. The outcome of the events was unknown.  Information on the lot/batch number has been requested.